Quick Answer
BRISTOL MYERS SQUIBB CO reported Total Revenue of $48.19 billion for fiscal year 2025.
BRISTOL MYERS SQUIBB CO — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | $48.19B -0.2% |
$48.30B +7.3% |
$45.01B -2.5% |
$46.16B -0.5% |
$46.38B +9.1% |
$42.52B +62.6% |
| Net Income | $7.05B +178.8% |
-$8.95B -211.5% |
$8.03B +26.8% |
$6.33B -9.5% |
$6.99B +177.6% |
-$9.02B -362.1% |
| Diluted EPS | $3.46 +178.5% |
-$4.41 -214.2% |
$3.86 +30.8% |
$2.95 -5.4% |
$3.12 +178.2% |
-$3.99 -298.5% |
| Total Assets | $90.04B -2.8% |
$92.60B -2.7% |
$95.16B -1.7% |
$96.82B -11.4% |
$109.31B -15.4% |
$129.28B +271.1% |
| Cash and Equivalents | $10.21B -1.3% |
$10.35B -9.8% |
$11.46B +25.7% |
$9.12B -34.7% |
$13.98B -11.6% |
$15.82B +115.6% |
| Long-Term Debt | $42.85B -10.0% |
$47.60B +29.9% |
$36.65B +4.6% |
$35.06B -11.5% |
$39.60B -18.1% |
$48.34B +11.4% |
| Stockholders Equity | $18.47B +13.1% |
$16.34B -44.5% |
$29.43B -5.3% |
$31.06B -13.6% |
$35.95B -28.1% |
$49.98B +226.3% |
| R&D Expense | $9.95B -10.8% |
$11.16B +20.0% |
$9.30B -2.2% |
$9.51B -6.7% |
$10.20B +1.5% |
$10.05B +63.4% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2025 | $12.22B | +2.8% | -0.4% |
| Net Income | September 30, 2025 | $2.20B | +81.8% | +68.0% |
| Diluted EPS | September 30, 2025 | $1.08 | +80.0% | +68.8% |
| Total Assets | September 30, 2025 | $96.89B | +3.4% | +2.3% |
| Cash and Equivalents | September 30, 2025 | $15.73B | +99.3% | +24.8% |
| Long-Term Debt | September 30, 2025 | $44.47B | -8.6% | -0.0% |
| Stockholders Equity | September 30, 2025 | $18.55B | +8.2% | +6.4% |
| R&D Expense | September 30, 2025 | $2.53B | +6.5% | -2.0% |
- BRISTOL MYERS SQUIBB CO reported Total Revenue of $48.19 billion for fiscal year 2025.
- BRISTOL MYERS SQUIBB CO showed a decrease of -0.2% in Total Revenue compared to the prior fiscal year.
- BRISTOL MYERS SQUIBB CO reported Net Income of $7.05 billion for fiscal year 2025.
- BRISTOL MYERS SQUIBB CO showed an increase of +178.8% in Net Income compared to the prior fiscal year.
- BRISTOL MYERS SQUIBB CO reported Diluted EPS of $3.46 per share for fiscal year 2025.
- BRISTOL MYERS SQUIBB CO showed an increase of +178.5% in Diluted EPS compared to the prior fiscal year.
- BRISTOL MYERS SQUIBB CO reported Total Assets of $90.04 billion for fiscal year 2025.
- BRISTOL MYERS SQUIBB CO showed a decrease of -2.8% in Total Assets compared to the prior fiscal year.
- BRISTOL MYERS SQUIBB CO reported Cash and Equivalents of $10.21 billion for fiscal year 2025.
- BRISTOL MYERS SQUIBB CO showed a decrease of -1.3% in Cash and Equivalents compared to the prior fiscal year.
- BRISTOL MYERS SQUIBB CO reported Long-Term Debt of $42.85 billion for fiscal year 2025.
- BRISTOL MYERS SQUIBB CO showed a decrease of -10.0% in Long-Term Debt compared to the prior fiscal year.
- BRISTOL MYERS SQUIBB CO reported Stockholders Equity of $18.47 billion for fiscal year 2025.
- BRISTOL MYERS SQUIBB CO showed an increase of +13.1% in Stockholders Equity compared to the prior fiscal year.
- BRISTOL MYERS SQUIBB CO reported R&D Expense of $9.95 billion for fiscal year 2025.
- BRISTOL MYERS SQUIBB CO showed a decrease of -10.8% in R&D Expense compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: